- Home
- CAH vs KVUE Comparison
CAH vs KVUE Comparison
Compare CAH & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- KVUE
- Stock Information
- Founded
- CAH 1979
- KVUE 2022
- Country
- CAH United States
- KVUE United States
- Employees
- CAH N/A
- KVUE N/A
- Industry
- CAH Other Pharmaceuticals
- KVUE Specialty Chemicals
- Sector
- CAH Health Care
- KVUE Consumer Discretionary
- Exchange
- CAH Nasdaq
- KVUE Nasdaq
- Market Cap
- CAH 37.6B
- KVUE 39.9B
- IPO Year
- CAH N/A
- KVUE 2023
- Fundamental
- Price
- CAH $157.45
- KVUE $16.27
- Analyst Decision
- CAH Buy
- KVUE Buy
- Analyst Count
- CAH 14
- KVUE 12
- Target Price
- CAH $161.43
- KVUE $21.58
- AVG Volume (30 Days)
- CAH 2.5M
- KVUE 37.3M
- Earning Date
- CAH 10-30-2025
- KVUE 11-06-2025
- Dividend Yield
- CAH 1.30%
- KVUE 5.16%
- EPS Growth
- CAH 86.96
- KVUE 28.77
- EPS
- CAH 6.45
- KVUE 0.74
- Revenue
- CAH $222,578,000,000.00
- KVUE $15,141,000,000.00
- Revenue This Year
- CAH $12.83
- KVUE N/A
- Revenue Next Year
- CAH $7.90
- KVUE $3.10
- P/E Ratio
- CAH $24.38
- KVUE $21.73
- Revenue Growth
- CAH N/A
- KVUE N/A
- 52 Week Low
- CAH $106.98
- KVUE $15.47
- 52 Week High
- CAH $168.44
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- CAH 59.00
- KVUE 30.95
- Support Level
- CAH $150.78
- KVUE $15.64
- Resistance Level
- CAH $159.24
- KVUE $16.30
- Average True Range (ATR)
- CAH 4.20
- KVUE 0.56
- MACD
- CAH 0.51
- KVUE 0.08
- Stochastic Oscillator
- CAH 90.28
- KVUE 24.82
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.